Literature DB >> 7939423

PCR for the diagnosis of enteroviral meningitis.

A Thorén1, A Widell.   

Abstract

A 2-step 'semi-nested' enterovirus PCR was developed and applied to CSF and serum specimens from 27 consecutive patients with aseptic meningitis. CSF and sera from 8 patients with non-enteroviral diagnoses were included as negative clinical controls. Enterovirus RNA was detected in CSF by PCR in 15 of the patients with aseptic meningitis, compared with 6 by virus culture. Acute-phase sera proved positive for enterovirus RNA in 11 patients, thus increasing the number of PCR-positive patients to 18. Convalescent-phase sera were all negative by PCR. The correlation of a positive or negative PCR result in CSF and/or serum versus combined conventional virology (serology and isolation from 1-3 sites, i.e. CSF, stool and throat) was 78%. All negative controls were negative by PCR. PCR is a reliable and sensitive diagnostic tool for the detection of enteroviral infections. Both CSF and acute-phase serum should be considered for testing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939423     DOI: 10.3109/00365549409011792

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  11 in total

Review 1.  Molecular techniques for clinical diagnostic virology.

Authors:  S J Read; D Burnett; C G Fink
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

2.  Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory.

Authors:  S J Read; K J Jeffery; C R Bangham
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Detection by PCR of enteroviruses in cerebrospinal fluid during a summer outbreak of aseptic meningitis in Switzerland.

Authors:  M Gorgievski-Hrisoho; J D Schumacher; N Vilimonovic; D Germann; L Matter
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Multicenter evaluation of the Amplicor Enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. The European Union Concerted Action on Viral Meningitis and Encephalitis.

Authors:  K E van Vliet; M Glimâker; P Lebon; P E Klapper; C E Taylor; M Ciardi; H G van der Avoort; R J Diepersloot; J Kurtz; M F Peeters; G M Cleator; A M van Loon
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay.

Authors:  S J Read; J B Kurtz
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  Evaluation of a commercially available reverse transcription-PCR assay for diagnosis of enteroviral infection in archival and prospectively collected cerebrospinal fluid specimens.

Authors:  F Pozo; I Casas; A Tenorio; G Trallero; J M Echevarria
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Enteroviral central nervous system infections in children of the region of monastir, Tunisia: diagnosis, laboratory findings of cerebrospinal fluid and clinical manifestations.

Authors:  Raida El Hiar; Samir Haddad; Hela Jaïdane; Didier Hober; Manel Ben M'hadheb-Gharbi; Maria Gullberg; Mohamed Neji-Guediche; A Michael Lindberg; Jawhar Gharbi; Mahjoub Aouni
Journal:  Indian J Virol       Date:  2012-09-04

9.  Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food.

Authors:  S M Abdel-Rahman; G L Kearns
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

10.  Risk factors for serious bacterial infection in febrile young infants in a community referral hospital.

Authors:  Seung Han Shin; Chang Won Choi; Jin-A Lee; Ee-Kyung Kim; Eun Hwa Choi; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.